1. Home
  2. GEL vs KNSA Comparison

GEL vs KNSA Comparison

Compare GEL & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEL
  • KNSA
  • Stock Information
  • Founded
  • GEL 1996
  • KNSA 2015
  • Country
  • GEL United States
  • KNSA United Kingdom
  • Employees
  • GEL N/A
  • KNSA N/A
  • Industry
  • GEL Oil Refining/Marketing
  • KNSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • GEL Energy
  • KNSA Health Care
  • Exchange
  • GEL Nasdaq
  • KNSA Nasdaq
  • Market Cap
  • GEL 1.3B
  • KNSA 1.3B
  • IPO Year
  • GEL 1996
  • KNSA 2018
  • Fundamental
  • Price
  • GEL $10.47
  • KNSA $18.73
  • Analyst Decision
  • GEL Buy
  • KNSA Strong Buy
  • Analyst Count
  • GEL 2
  • KNSA 5
  • Target Price
  • GEL $16.00
  • KNSA $36.60
  • AVG Volume (30 Days)
  • GEL 482.2K
  • KNSA 469.7K
  • Earning Date
  • GEL 02-13-2025
  • KNSA 02-26-2025
  • Dividend Yield
  • GEL 6.29%
  • KNSA N/A
  • EPS Growth
  • GEL N/A
  • KNSA N/A
  • EPS
  • GEL N/A
  • KNSA N/A
  • Revenue
  • GEL $3,014,767,000.00
  • KNSA $384,098,000.00
  • Revenue This Year
  • GEL N/A
  • KNSA $60.05
  • Revenue Next Year
  • GEL $0.97
  • KNSA $36.74
  • P/E Ratio
  • GEL N/A
  • KNSA N/A
  • Revenue Growth
  • GEL N/A
  • KNSA 54.41
  • 52 Week Low
  • GEL $9.86
  • KNSA $16.56
  • 52 Week High
  • GEL $15.17
  • KNSA $28.15
  • Technical
  • Relative Strength Index (RSI)
  • GEL 46.87
  • KNSA 38.56
  • Support Level
  • GEL $10.25
  • KNSA $18.27
  • Resistance Level
  • GEL $10.61
  • KNSA $19.05
  • Average True Range (ATR)
  • GEL 0.33
  • KNSA 0.61
  • MACD
  • GEL 0.09
  • KNSA -0.05
  • Stochastic Oscillator
  • GEL 53.16
  • KNSA 34.42

About GEL Genesis Energy L.P. Common Units

Genesis Energy LP is a United States-based limited partnership that focuses on the midstream segment of the crude oil and natural gas industry. It engages in providing services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are offshore pipeline transportation, sodium minerals, and sulfur services, onshore facilities and transportation, and marine transportation. It generates maximum revenue from the offshore pipeline transportation segment which conducts crude oil and natural gas pipeline transportation and handling operations in the Gulf of Mexico through its offshore pipeline transportation segment, which focuses on providing a suite of services to integrated and large independent energy companies.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Share on Social Networks: